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Silvia J. Serrano-Gómez1,2, Marı́a Carolina Sanabria-Salas1, Jone Garay3, Melody
C. Baddoo4, Gustavo Hernández-Suarez1, Juan Carlos Mejı́a5, Oscar Garcı́a6,
Lucio Miele7, Laura Fejerman8☯, Jovanny Zabaleta3,9☯*
1 Grupo de investigación en Biologı́a del Cáncer, Instituto Nacional de Cancerologı́a, Bogotá D. C, Colombia,
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Hispanic/Latino populations are a genetically admixed and heterogeneous group, with vari-
able fractions of European, Indigenous American and African ancestries. The molecular pro-
file of breast cancer has been widely described in non-Hispanic Whites but equivalent
knowledge is lacking in Hispanic/Latinas. We have previously reported that the most preva-
lent breast cancer intrinsic subtype in Colombian women was Luminal B as defined by
St. Gallen 2013 criteria. In this study we explored ancestry-associated differences in molec-
ular profiles of Luminal B tumors among these highly admixed women.
Methods
We performed whole-transcriptome RNA-seq analysis in 42 Luminal tumors (21 Luminal A
and 21 Luminal B) from Colombian women. Genetic ancestry was estimated from a panel of
80 ancestry-informative markers (AIM). We categorized patients according to Luminal sub-
type and to the proportion of European and Indigenous American ancestry and performed
differential expression analysis comparing Luminal B against Luminal A tumors according to
the assigned ancestry groups.
Results
We found 5 genes potentially modulated by genetic ancestry: ERBB2 (log2FC = 2.367,
padj<0.01), GRB7 (log2FC = 2.327, padj<0.01), GSDMB (log2FC = 1.723, padj<0.01,
MIEN1 (log2FC = 2.195, padj<0.01 and ONECUT2 (log2FC = 2.204, padj<0.01). In the
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